semaglutide clinical trials Weekly improves blood sugar and weight in adults with type 1 diabetes, trial finds Wegovy shown to reduce risk

Achieve sustainable weight loss with a personalized compounded GLP-1 injection plan from Refills

Headaches affect some patients starting GLP-1 therapy

This compound is currently being studied for its potential in metabolic and obesity-related pathways, particularly involving triple receptor agonists (GLP-1/GIP/Glucagon)

Injection: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL in a single-dose pen The recommended starting dosage is 2.5 mg injected subcutaneously once weekly

Learn how these two emerging weight loss injections work, their benefits, differences, and which may suit your health goals.

The framework prioritised semaglutide and tirzepatide as first-line treatments, based on evidence of 15% weight loss and benefits in complications such as cardiovascular disease and sleep apnoea